Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
60.52
+2.28 (3.91%)
At close: Jan 21, 2025, 4:00 PM
58.17
-2.35 (-3.88%)
After-hours: Jan 21, 2025, 4:05 PM EST
Disc Medicine Employees
Disc Medicine had 74 employees as of December 31, 2023. The number of employees increased by 28 or 60.87% compared to the previous year.
Employees
74
Change (1Y)
28
Growth (1Y)
60.87%
Revenue / Employee
n/a
Profits / Employee
-$1,398,365
Market Cap
1.80B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 74 | 28 | 60.87% |
Dec 31, 2022 | 46 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IRON News
- 7 hours ago - Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 15 hours ago - Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission - GlobeNewsWire
- 1 day ago - Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 4 days ago - Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 2 months ago - Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. - GlobeNewsWire